$VNOV

VitaNova Life Sciences Corp

VitaNova Life Sciences is a U.S.-focused consumer health, beauty and lifestyle company that develops, acquires, markets and sells nutritional supplements, functional beverages and other lifestyle products. Its dietary supplement business operates through wholly owned subsidiary NutriPeak Trading Corporation and uses the GeneCode and AMZ brands. GeneCode offers wellness-oriented formulations, while AMZ focuses on accessible everyday nutritional supplements. VitaNova primarily sells through a business-to-business model, working with regional distributors and channel partners, and also uses direct-to-consumer, livestreaming, retail and wellness-service channels. VitaNova also provides business-advisory and administrative services to third parties. Its newer healthy-food product line includes olive juice, white sesame oil and aloe vera drink; wholly owned subsidiary VitaNova Global Foods Corporation handles related food trading activities. The company oversees product strategy, formulation, brands and regulatory compliance, while third parties manufacture, package and fulfill products. VitaNova is headquartered in New York, New York.

No enriched coverage for $VNOV in the last 7 days.

No SEC Form 4 filings for $VNOV in the last 30 days.

See all $VNOV insider activity →
Med

A 210% sales surge leaves VitaNova (VNOV) deeper in the red

VitaNova (VNOV) reported a 210% revenue increase to $321,576 for the quarter ended July 31, 2026, driven by new food products. However, gross margin dropped to 9% from 66%, and net loss widened to $123,101. The company cited internal control weaknesses but stated it has sufficient liquidity for the next 12 months.

VNOV sentiment & insider activity

What's driving VNOV

AlphAI scores every news story that mentions VNOV with an AI model for sentiment and relevance, and aggregates insider trades from VitaNova Life Sciences Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $VNOV

Score

Related tickers